Routine use of postoperative intravesical chemotherapy after TURBT-Should it be done?

Urology

Volumn 76, Issue 4, 2010, Pages 794-796

  Soloway, Mark S ^a   Arianayagam, Mohan ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; EPIRUBICIN; MITOMYCIN C; THIOTEPA; ANTINEOPLASTIC AGENT;

ARTICLE; BLADDER CANCER; BLADDER TUMOR; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER TRANSPLANTATION; CARCINOGENICITY; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; TRANSURETHRAL RESECTION OF BLADDER TUMOR; TUMOR CELL; ADJUVANT CHEMOTHERAPY; CANCER INVASION; INTRAVESICAL DRUG ADMINISTRATION; MULTIMODALITY CANCER THERAPY; PATHOLOGY; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; RISK; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR SEEDING; UTILIZATION REVIEW;

ADMINISTRATION, INTRAVESICAL; ANTINEOPLASTIC AGENTS; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; GUIDELINE ADHERENCE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM SEEDING; POSTOPERATIVE PERIOD; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 77957734479     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.04.069     Document Type: Article

References (16)

1. D. Lamm, M. Colombel, and R. Persad Clinical practice recommendations for the management of non muscle invasive bladder cancer Eur Urol Supplements 7 2008 651 666
2. R.J. Sylvester, A.P. van der Meijden, and W. Oosterlinck Predicting recurrence and progression in individual patients with stage T(a) T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials Eur Urol 49 2006 466465
3. R.J. Sylvester, W. Oosterlinck, and A.P. van der Meijden A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage T(a) T1 bladder cancer: a meta-analysis of published results of randomized clinical trials J Urol 171 2004 2186 2190 [Quiz:2435]
4. K.T. Adiyat, D. Katkoori, and C.T. Soloway Complete transurethral resection of bladder tumor: are the guidelines being followed? Urology 75 2010 365 367
5. T.E. Weldon, and M.S. Soloway Susceptibility of urothelium to neoplastic cellular implantation Urology 5 1975 824 827
6. E. Kaasinen, E. Rintala, and P. Hellstrom Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma Eur Urol 42 2002 167 174
7. S. Gudjonsson, L. Adell, and F. Merdasa Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre study Eur Urol 55 2009 773 780
8. W. Oosterlinck, E. Solsona, and H. Akaza Low grade, Ta (noninvasive) urothelial carcinoma of the bladder M.S. Soloway, A. Carmack, S. Khoury, Bladder Tumors 2006 Health Publication, Ltd Paris
9. M. Babjuk, W. Oosterlinck, and R. Sylvester EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder Eur Urol 54 2008 303 314
10. M.C. Hall, S.S. Chang, and G. Dalbagni Guideline for the management of nonmuscle invasive bladder cancer (stages T(a,T1), and Tis): 2007 update J Urol 178 2007 2314 2330
11. D.A. Tolley, M.K. Parmar, and K.M. Grigor The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up J Urol 155 1996 1233 1238
12. E. Solsona, I. Iborra, and J.V. Ricos Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup J Urol 161 1999 1120 1123
13. F.N. Joudi, B.J. Smith, and M.A. O'Donnell Contemporary management of superficial bladder cancer in the United States: a pattern of care analysis Urology 62 2003 1083 1088
14. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillationexecutive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to revise the 2001 guidelines for the management of patients with atrial fibrillation) J Am Coll Cardiol 48 2006 854 906 (Pubitemid 44175743)
15. R.W. Carlson, E. Brown, and H.J. Burstein NCCN Task Force Report: adjuvant therapy for breast cancer J Natl Compr Cancer Netw 4 Suppl 1 2006 S1 S26
16. E. Solsona Early single instillation chemotherapy is very beneficial and should be the standard approach in non muscle invasive bladder cancer Eur Urol Supplements 8 2009 464 469